U.S. markets close in 4 hours 4 minutes
  • S&P 500

    3,769.49
    -55.84 (-1.46%)
     
  • Dow 30

    30,551.70
    -545.56 (-1.75%)
     
  • Nasdaq

    11,096.74
    -31.11 (-0.28%)
     
  • Russell 2000

    1,697.23
    -30.52 (-1.77%)
     
  • Crude Oil

    99.17
    -9.26 (-8.54%)
     
  • Gold

    1,766.10
    -35.40 (-1.97%)
     
  • Silver

    19.09
    -0.58 (-2.93%)
     
  • EUR/USD

    1.0260
    -0.0165 (-1.58%)
     
  • 10-Yr Bond

    2.7910
    -0.0980 (-3.39%)
     
  • GBP/USD

    1.1934
    -0.0170 (-1.40%)
     
  • USD/JPY

    135.6720
    +0.0120 (+0.01%)
     
  • BTC-USD

    19,488.19
    -318.46 (-1.61%)
     
  • CMC Crypto 200

    421.80
    -18.22 (-4.14%)
     
  • FTSE 100

    7,025.47
    -207.18 (-2.86%)
     
  • Nikkei 225

    26,423.47
    +269.66 (+1.03%)
     

What You Need To Know About The Chemours Company's (NYSE:CC) Investor Composition

  • Oops!
    Something went wrong.
    Please try again later.
·4 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Every investor in The Chemours Company (NYSE:CC) should be aware of the most powerful shareholder groups. Large companies usually have institutions as shareholders, and we usually see insiders owning shares in smaller companies. Companies that used to be publicly owned tend to have lower insider ownership.

Chemours is a pretty big company. It has a market capitalization of US$4.4b. Normally institutions would own a significant portion of a company this size. In the chart below, we can see that institutions are noticeable on the share registry. We can zoom in on the different ownership groups, to learn more about Chemours.

See our latest analysis for Chemours

ownership-breakdown
ownership-breakdown

What Does The Institutional Ownership Tell Us About Chemours?

Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.

Chemours already has institutions on the share registry. Indeed, they own a respectable stake in the company. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It's therefore worth looking at Chemours' earnings history below. Of course, the future is what really matters.

earnings-and-revenue-growth
earnings-and-revenue-growth

Investors should note that institutions actually own more than half the company, so they can collectively wield significant power. Our data indicates that hedge funds own 5.1% of Chemours. That worth noting, since hedge funds are often quite active investors, who may try to influence management. Many want to see value creation (and a higher share price) in the short term or medium term. The Vanguard Group, Inc. is currently the company's largest shareholder with 10% of shares outstanding. BlackRock, Inc. is the second largest shareholder owning 8.8% of common stock, and FMR LLC holds about 8.6% of the company stock.

Looking at the shareholder registry, we can see that 51% of the ownership is controlled by the top 14 shareholders, meaning that no single shareholder has a majority interest in the ownership.

Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. There are a reasonable number of analysts covering the stock, so it might be useful to find out their aggregate view on the future.

Insider Ownership Of Chemours

The definition of an insider can differ slightly between different countries, but members of the board of directors always count. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it.

Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group.

We can see that insiders own shares in The Chemours Company. The insiders have a meaningful stake worth US$54m. Most would see this as a real positive. It is good to see this level of investment by insiders. You can check here to see if those insiders have been buying recently.

General Public Ownership

The general public, who are usually individual investors, hold a 21% stake in Chemours. While this group can't necessarily call the shots, it can certainly have a real influence on how the company is run.

Next Steps:

While it is well worth considering the different groups that own a company, there are other factors that are even more important. For example, we've discovered 3 warning signs for Chemours that you should be aware of before investing here.

If you are like me, you may want to think about whether this company will grow or shrink. Luckily, you can check this free report showing analyst forecasts for its future.

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.